2B4 dysfunction in XLP1 NK cells: More than inability to control EBV infection

Clin Immunol. 2019 Jul:204:31-36. doi: 10.1016/j.clim.2018.10.022. Epub 2018 Nov 2.

Abstract

X-linked lymphoproliferative disease 1 (XLP1) is a monogenic disorder caused by mutations in SH2D1A, resulting in the absence/dysfunction of the signaling lymphocyte activation molecule (SLAM)-associated protein (SAP). Consequently, SLAM receptors as 2B4 (CD244) and NTB-A (SLAMF6), upon ligand engagement, exert inhibitory instead of activating function. This causes an immune dysfunction that is worsened by the selective inability of NK and T cells to kill EBV-infected B cells with dramatic clinical sequelae (e.g. fulminant mononucleosis, hyperinflammation, lymphoma). Here we outline recent findings on the interplay between inhibitory 2B4 and the various activating receptors in NK cells. 2B4 engagement selectively blocks ITAM-dependent activating receptors as NCR and CD16, while it does not affect NKG2D and DNAM-1. Furthermore, inhibitory 2B4 participates to NK cell education, as highlighted by the existence in XLP1 patients of a large subset of fully functional NK cells that lack self-HLA specific inhibitory receptors and exert autoreactivity against mature dendritic cells.

Keywords: 2B4; NK cells; NK receptors; NK-cell education; SAP; XLP1.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Epstein-Barr Virus Infections / immunology*
  • Humans
  • Immunologic Deficiency Syndromes / immunology*
  • Immunologic Deficiency Syndromes / metabolism
  • Killer Cells, Natural / immunology*
  • Killer Cells, Natural / metabolism
  • Lymphoproliferative Disorders / immunology*
  • Lymphoproliferative Disorders / metabolism
  • Male
  • Signaling Lymphocytic Activation Molecule Family / immunology*
  • Signaling Lymphocytic Activation Molecule Family / metabolism

Substances

  • CD244 protein, human
  • Signaling Lymphocytic Activation Molecule Family